Bicycle Therapeutics plc Weighted Average Number of Shares Outstanding, Basic and Diluted
Bicycle Therapeutics plc (BCYC) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 22.10 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-06
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 22.10M shares, a 22.80% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 21.06M shares, a 17.47% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 19.43M shares, a 8.52% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 18.08M shares, a 147.70% increase year-over-year.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 19.15M shares, a 73.34% increase from fiscal 2019.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 11.05M shares, a 2416.82% increase from fiscal 2018.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 438.86K shares, a 31.74% increase from fiscal 2017.
- Bicycle Therapeutics plc weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 333.13K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | 22.10M shares 10-Q · filed 2021-05-06 | 21.58M shares derived: average of 2 quarters · filed 2021-05-06 | 20.86M shares derived: average of 3 quarters · filed 2021-05-06 | 20.17M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 21.06M shares 10-K · filed 2021-03-11 | 20.24M shares derived: average of 2 quarters · filed 2021-03-11 | 19.52M shares derived: average of 3 quarters · filed 2021-03-11 | 19.15M shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 19.43M shares 10-K · filed 2021-03-11 | 18.75M shares derived: average of 2 quarters · filed 2021-03-11 | 18.50M shares 10-Q · filed 2020-11-05 | 18.36M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2020-06-30 | 18.08M shares 10-K · filed 2021-03-11 | 18.02M shares 10-Q · filed 2020-08-05 | 18.00M shares derived: average of 3 quarters · filed 2021-05-06 | 17.98M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2020-03-31 | 18.00M shares 10-Q · filed 2021-05-06 | 17.96M shares derived: average of 2 quarters · filed 2021-05-06 | 17.94M shares derived: average of 3 quarters · filed 2021-05-06 | 15.28M shares derived: average of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | 17.93M shares 10-K · filed 2021-03-11 | 17.91M shares derived: average of 2 quarters · filed 2021-03-11 | 14.38M shares derived: average of 3 quarters · filed 2021-03-11 | 11.05M shares 10-K · filed 2021-03-11 |
| 2019-09-30 | 17.90M shares 10-K · filed 2021-03-11 | 12.60M shares derived: average of 2 quarters · filed 2021-03-11 | 8.73M shares 10-Q · filed 2020-11-05 | 6.63M shares derived: average of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | 7.30M shares 10-K · filed 2021-03-11 | 4.10M shares 10-Q · filed 2020-08-05 | 2.88M shares derived: average of 3 quarters · filed 2021-03-11 | 2.27M shares derived: average of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | 834.04K shares 10-K · filed 2021-03-11 | 668.68K shares derived: average of 2 quarters · filed 2021-03-11 | 590.38K shares derived: average of 3 quarters · filed 2021-03-11 | 547.80K shares derived: average of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | 503.31K shares 10-K · filed 2020-03-10 | 468.55K shares derived: average of 2 quarters · filed 2020-03-10 | 452.39K shares derived: average of 3 quarters · filed 2020-03-10 | 438.86K shares 10-K · filed 2021-03-11 |
| 2018-09-30 | 433.80K shares 10-K · filed 2020-03-10 | 426.93K shares derived: average of 2 quarters · filed 2020-03-10 | 417.22K shares 10-Q · filed 2019-11-07 | |
| 2018-06-30 | 420.06K shares 10-K · filed 2020-03-10 | 408.81K shares 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | 397.48K shares 10-K · filed 2020-03-10 | |||
| 2017-12-31 | 333.13K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |